帕利哌酮棕榈酸酯引起的迟发性运动障碍病例报告。
A case of paliperidone-palmitate-induced tardive dyskinesia.
机构信息
National University of Ireland Galway, Galway, Ireland.
出版信息
Gen Hosp Psychiatry. 2013 Mar-Apr;35(2):213.e5-7. doi: 10.1016/j.genhosppsych.2012.04.009. Epub 2012 Jun 14.
Abstract
OBJECTIVES
This is one of the first cases reported in the literature of paliperidone-palmitate-induced prolonged dyskinesia.
METHOD
Case report.
RESULTS
We report the case of a 49-year-old woman with paranoid schizophrenia who developed orofacial dyskinesia some 4 months after the commencement of paliperidone long-acting injection.
CONCLUSION
This case serves as a clinical reminder that dyskinesia can occur with all antipsychotic medications.
摘要
目的
这是文献中首次报道的棕榈酸帕利哌酮引起的迟发性运动障碍病例之一。
方法
病例报告。
结果
我们报告了一例 49 岁的偏执型精神分裂症女性患者，在接受棕榈酸帕利哌酮长效注射治疗约 4 个月后出现口面部运动障碍。
结论
本病例提醒临床医生，所有抗精神病药物都可能引起运动障碍。
Zotero 插件